India Pharma Exports Reach $31 Billion Amid US Tariff Threat

Pharma Exports India’s pharmaceutical shipments topped US$31 billion in FY26, according to IBEF, showing solid growth despite global market headwinds and currency pressures, and reinforces India’s role as a leading exporter.

US Tariffs The United States announced tariffs of up to 200 percent on selected Indian generic medicines, targeting active pharmaceutical ingredients and finished dosage forms, raising cost concerns for American buyers, impacting a wide range of therapeutic classes.

API Buyers Industry analysts warn that the steep tariff levels could force API purchasers to seek alternative sources, potentially shifting supply chains toward Europe or China and squeezing profit margins for Indian exporters, and could erode competitive pricing advantages.

Government Response The Indian Ministry of Commerce said it will engage Washington through diplomatic channels and explore subsidy measures to protect domestic manufacturers while maintaining the sector’s contribution to the national economy, while seeking relief through trade negotiations.